Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Renovaro Biosciences (RENB) has shared an update.
Leni Boeren has resigned from the Board of Directors of Renovaro Inc., effective June 27, 2024, to attend to family health matters. Her departure is not due to any disagreements with the company’s management or practices, where she notably served as chair of the special litigation committee.
For a thorough assessment of RENB stock, go to TipRanks’ Stock Analysis page.